Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

Clinical trial NCT03620643 · COMPLETED

Trial details

NCT number: NCT03620643
Sponsor: Royal Marsden NHS Foundation Trust
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lobular Breast Carcinoma Gastric Cancer Triple Negative Breast Cancer CDH1 Gene Mutation

Start date: 2019-05-09
Primary completion: 2024-08-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.